Archive for the ‘DNAtrix Inc’ Category

DNAtrix Inc

October 16th, 2014 | Posted in 2014, DNAtrix Inc

DNAtrix Inc‘s DNX-2401 was granted Orphan Drug Status by the FDA DNX-2041 is a conditionally-replicative oncolytic adenovirus for maligent glioma. DNAtris is a privately held company in San Diego and Houston.